Reporter Sept 9 2016

Restore T cells to fight leukemia

Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients.

Risk factors for delirium

High levels of blood markers for vascular endothelial dysfunction were associated with longer periods of confusion in ICU patients, Vanderbilt researchers have discovered.

In search of new cancer targets

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

drawing of trojan horse

Investigators create ‘Trojan Horse’ to fight Ebola

A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus.

Going after the ‘heart attack gremlin’

A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target.

Proposed changes could impact liver transplant efforts

A new proposal under consideration by the United Network of Organ Sharing (UNOS) that would change the way donated livers are distributed would negatively impact patients listed for liver transplantation at Vanderbilt University Medical Center (VUMC) and across the Southeast, according to Seth Karp, M.D., H. William Scott Jr. Professor and chair of the Department of Surgery.

1 2